Stephens has recently initiated Inovio Pharmaceuticals Inc (INO) stock to Overweight rating, as announced on May 14, 2024, according to Finviz. Earlier, on January 25, 2024, Oppenheimer had raised the ...

Inovio Pharmaceuticals Inc. closed $12.47 short of its 52-week high ($14.75), which the company reached on April 1st.

Inovio Pharmaceuticals shares are trading higher by 20.7% Tuesday afternoon. Vaccine stocks are rising amid growing concerns ...

Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more here.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Stay informed with Seeking Alpha's Catalyst Watch - a breakdown of upcoming events impacting stock prices next week.

Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.

The upside in Precigen's stock comes after it completes the rolling submission of an FDA filing for its first potentially marketed product.

Foxtel sold for $3.4 billion to a British streaming outfit, while the ASX 200 gained 1.7 per cent, recouping much of last week's losses. Here's how the day's trade unfolded, with insights from our ...